An H-I-V drug capable of letting patients live a completely normal life has been added to Australia’s Pharmaceutical Benefits Scheme today.
More than 27,500 Australians are currently living with H-I-V.
Now, adults diagnosed with the H-I-V-one infection will be able to easily access the powerful triple-therapy Biktarvy drug. Read More
